J. Gere

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.

David K Howse, A. Verier, M. Valis, 2018, Multiple sclerosis and related disorders.

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

Ousmane A Camara, C. Carel, P. Vermersch, 2022, Neurology and Therapy.

Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke

E. Vicaut, D. Leys, A. Leger, 2020, Stroke.

Parietal operculum and motor cortex activities predict motor recovery in moderate to severe stroke

Laurent Lamalle, Thomas A. Zeffiro, Félix Renard, 2017, NeuroImage: Clinical.

Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait

Eric Bardinet, Jérôme Yelnik, Paul Krack, 2016, Movement disorders : official journal of the Movement Disorder Society.

Immunization and multiple sclerosis: Recommendations from the French Multiple Sclerosis Society.

C. Louapre, S. Vukusic, C. Mékiès, 2019, Revue neurologique.